• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    3/24/23 1:03:34 PM ET
    $ADMA
    $ALLR
    $BAOS
    $BOXD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADMA alert in real time by email

    Gainers

    • Near Intelligence Inc. (NASDAQ:NIR) shares climbed 53.1% to $16.50.
    • Silvergate Capital Corporation (NYSE:SI) climbed 48% to $1.67 on rumor suggesting a crypto exchange is trying to buy Silvergate's trade processing technologies.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) gained 33.9% to $2.2499 after jumping 25% on Thursday. Maxim Group maintained Dermata Therapeutics with a Buy and lowered the price target from $16 to $4.
    • NaaS Technology Inc. (NASDAQ:NAAS) jumped 25.7% to $5.24. NaaS Technology will hold an annual general meeting of shareholders on April 19, 2023.
    • GH Research PLC (NASDAQ:GHRS) gained 25.5% to $8.68.
    • Vaccitech plc (NASDAQ:VACC) climbed 25.4% to $2.8355 after the company reported better-than-expected FY22 sales results.
    • Troika Media Group, Inc. (NASDAQ:TRKA) rose 23.4% to $0.2205.
    • GD Culture Group Limited (NASDAQ:GDC) gained 22.8% to $3.2899.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) jumped 21.5% to $2.09.
    • Bird Global, Inc. (NYSE:BRDS) shares rose 19.3% to $0.1691 after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring.
    • Torrid Holdings Inc. (NYSE:CURV) gained 18.1% to $2.81 after the company reported Q4 results.
    • Vicarious Surgical Inc. (NYSE:RBOT) jumped 16% to $1.74.
    • Usio, Inc. (NASDAQ:USIO) jumped 15.7% to $1.98.
    • Xcel Brands, Inc. (NASDAQ:XELB) gained 14.5% to $0.70.
    • Vor Biopharma Inc. (NASDAQ:VOR) jumped 13.7% to $5.80 following a narrower-than-expected quarterly loss.
    • ReNew Energy Global Plc (NASDAQ:RNW) gained 13.6% to $4.99.
    • Reading International, Inc. (NASDAQ:RDIB) surged 8% to $22.14.
    • ADMA Biologics, Inc. (NASDAQ:ADMA) shares climbed 6.8% to $3.3215 after the company reported better-than-expected Q4 sales results and issued FY23 revenue guidance above estimates.

    Losers

    • Boxed, Inc. (NYSE:BOXD) fell 35.8% to $0.2209 after gaining 91% on Thursday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares dropped 32% to $0.0767 after the company announced a reverse stock split of its common stock.
    • FiscalNote Holdings, Inc. (NYSE:NOTE) shares tumbled 29.4% to $1.6799. FiscalNote shares jumped 75% on Thursday after the company announced it was selected by OpenAI for collaboration as an inaugural launch partner for OpenAI's ChatGPT plug-in.
    • Hyzon Motors Inc. (NASDAQ:HYZN) fell 25.4% to $0.7456.
    • Scholastic Corporation (NASDAQ:SCHL) fell 23% to $31.82 after the company said Q3 adjusted EPS and sales results were lower year over year.
    • YS Biopharma Co., Ltd. (NASDAQ:YS) dipped 22% to $10.14.
    • Sentage Holdings Inc. (NASDAQ:SNTG) dropped 20.8% to $2.05.
    • DiamondHead Holdings Corp. (NASDAQ:DHHC) fell 19.8% to $15.15 after gaining more than 82% on Thursday. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) dropped 17.7% to $1.1750. HC Wainwright & Co. reiterated Cidara Therapeutics with a Buy and maintained a $6 price target.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) fell 17.7% to $3.53.
    • Express, Inc. (NYSE:EXPR) fell 16.2% to $0.7122 after the company reported worse-than-expected Q4 sales results.
    • Flora Growth Corp. (NASDAQ:FLGC) fell 15.4% to $0.2360. Flora Growth is expected to host its 2022 year-end earnings call on Monday, April 3, 2023.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares fell 14.2% to $1.10 after jumping over 35% on Thursday.
    • Oxford Industries, Inc. (NYSE:OXM) dropped 13.2% to $101.06 after the company issued Q1 adjusted EPS guidance below estimates.
    • Ouster, Inc. (NYSE:OUST) fell 12.5% to $0.7909 after the company reported downbeat Q4 results and issued weak Q1 sales forecast.
    • PepGen Inc. (NASDAQ:PEPG) fell 12.3% to $14.79 following Q4 results.
    • Invivyd, Inc. (NASDAQ:IVVD) dropped 11.2% to $1.2685. Invivyd posted a FY22 loss of $2.23 per share.
    • Lilium N.V. (NASDAQ:LILM) fell 10.8% to $0.7089.
    • Heron Therapeutics, Inc. (NASDAQ:HRTX) fell 10.7% to $1.8450 after posting Q4 results.
    • Proterra Inc. (NASDAQ:PTRA) dropped 10.1% to $1.5199.
    • PARTS iD, Inc. (NYSE:ID) fell 8.6% to $0.2146.
    • Farfetch Limited (NYSE:FTCH) fell 7% to $4.3450. Citigroup maintained Farfetch with a Sell and lowered the price target from $6 to $4.
    • Getty Images Holdings, Inc. (NYSE:GETY) fell 6.9% to $3.75.

    Now Read This: Bitcoin, Ethereum Move Higher; Mask Network, Mina Among Top Gainers

    Get the next $ADMA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADMA
    $ALLR
    $BAOS
    $BOXD

    CompanyDatePrice TargetRatingAnalyst
    Oxford Industries Inc.
    $OXM
    4/22/2026$36.00 → $51.00Market Perform
    Telsey Advisory Group
    ADMA Biologics Inc
    $ADMA
    4/21/2026$21.00Buy
    Canaccord Genuity
    Vor Biopharma Inc.
    $VOR
    3/30/2026$50.00Buy
    Jefferies
    Oxford Industries Inc.
    $OXM
    3/27/2026$40.00 → $36.00Market Perform
    Telsey Advisory Group
    ADMA Biologics Inc
    $ADMA
    3/26/2026Overweight → Neutral
    Cantor Fitzgerald
    Vor Biopharma Inc.
    $VOR
    3/19/2026$30.00Overweight
    Wells Fargo
    Scholastic Corporation
    $SCHL
    3/9/2026Buy → Neutral
    B. Riley Securities
    Oxford Industries Inc.
    $OXM
    1/13/2026$35.00 → $40.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Frichtl Mark exercised 400 shares at a strike of $2.13 and sold $12,000 worth of shares (400 units at $30.00) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Ouster, Inc. (0001816581) (Issuer)

    4/23/26 5:54:33 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by D Loren Robert W

    4 - XCel Brands, Inc. (0001083220) (Issuer)

    4/22/26 7:24:01 PM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    SEC Form 4 filed by Disanto Mark

    4 - XCel Brands, Inc. (0001083220) (Issuer)

    4/22/26 7:22:17 PM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    SEC Filings

    View All

    Amendment: SEC Form S-3/A filed by Allarity Therapeutics Inc.

    S-3/A - Allarity Therapeutics, Inc. (0001860657) (Filer)

    4/24/26 1:01:50 PM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form F-1/A filed by NaaS Technology Inc.

    F-1/A - NaaS Technology Inc. (0001712178) (Filer)

    4/24/26 11:44:26 AM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form S-1/A filed by Xcel Brands Inc.

    S-1/A - XCel Brands, Inc. (0001083220) (Filer)

    4/23/26 5:45:26 PM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

    4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)

    3/17/26 5:44:21 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:42:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard bought $14,840 worth of shares (1,000 units at $14.84), increasing direct ownership by 8% to 13,666 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:34:29 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Xcel Brands & Gemma Stafford Launch GemmaMade on QVC

    NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ:XELB), an industry leading media and consumer products company specializing in building influencer-driven brands through social commerce and live streaming, is excited to announce International Baking Star, chef and creator of the YouTube sensation Bigger Bolder Baking, Gemma Stafford, will be premiering GemmaMade by Gemma Stafford on QVC Sunday, April 26th, 2026. For her debut collection, GemmaMade by Gemma Stafford draws inspiration from her Irish heritage, featuring signature kitchen pieces designed to bring the spirit of Ireland into the home. Rooted in her belief that the kitchen is the heart of the home, the collection

    4/24/26 10:00:00 AM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    Scholastic Corporation Announces Final Results of Modified Dutch Auction Tender Offer

    NEW YORK, April 23, 2026 /PRNewswire/ -- Scholastic Corporation (the "Company" or "Scholastic") (NASDAQ:SCHL), the global children's publishing, education and media company, today announced the final results of its "modified Dutch Auction" tender offer for shares of its common stock, which expired at 5:00 p.m., New York City time, on April 20, 2026. Based on the final count by Computershare Trust Company, N.A., the depositary for the tender offer, a total of 2,834,018 shares of Scholastic's common stock, par value $0.01 per share (each share of Scholastic's common stock, a "Shar

    4/23/26 7:00:00 AM ET
    $SCHL
    Books
    Consumer Discretionary

    Ouster BlueCity Selected for Major Traffic Signal Management and Road Safety Deployments Across 30+ Intersections in and around Atlanta, Georgia

    Ouster BlueCity to be deployed in an additional 30+ intersections in Atlanta and surrounding areas, including around the downtown Mercedes-Benz Stadium, in preparation for the 2026 FIFA World Cup The system will integrate directly into GDOT's traffic controller to support traffic signal management and vulnerable road user safety events Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, today announced that its turnkey traffic management solution, Ouster BlueCity, will be deployed at more than 30 intersections across the greater Atlanta area. This initiative is a collaborative effort with the Georgia Department of Transportation

    4/23/26 6:00:00 AM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Oxford Industries with a new price target

    Telsey Advisory Group reiterated coverage of Oxford Industries with a rating of Market Perform and set a new price target of $51.00 from $36.00 previously

    4/22/26 6:45:43 AM ET
    $OXM
    Garments and Clothing
    Industrials

    Canaccord Genuity initiated coverage on ADMA Biologics with a new price target

    Canaccord Genuity initiated coverage of ADMA Biologics with a rating of Buy and set a new price target of $21.00

    4/21/26 7:30:27 AM ET
    $ADMA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Jefferies initiated coverage on Vor Biopharma with a new price target

    Jefferies initiated coverage of Vor Biopharma with a rating of Buy and set a new price target of $50.00

    3/30/26 8:22:03 AM ET
    $VOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    Leadership Updates

    Live Leadership Updates

    View All

    Xcel Brands & Gemma Stafford Launch GemmaMade on QVC

    NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ:XELB), an industry leading media and consumer products company specializing in building influencer-driven brands through social commerce and live streaming, is excited to announce International Baking Star, chef and creator of the YouTube sensation Bigger Bolder Baking, Gemma Stafford, will be premiering GemmaMade by Gemma Stafford on QVC Sunday, April 26th, 2026. For her debut collection, GemmaMade by Gemma Stafford draws inspiration from her Irish heritage, featuring signature kitchen pieces designed to bring the spirit of Ireland into the home. Rooted in her belief that the kitchen is the heart of the home, the collection

    4/24/26 10:00:00 AM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    Ouster Appoints Chief Revenue Officer to Further Accelerate Commercial Growth

    Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, announced today the appointment of Cyrille Jacquemet to Chief Revenue Officer. In this expanded capacity, Cryille has been designated a Section 16 officer of the Company. He will continue to lead global sales, marketing, and customer success as Ouster continues to scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414194061/en/Cyrille Jacquemet, Chief Revenue Officer, Ouster "Cyrille's appointment to Chief Revenue Officer recognizes his exceptional impact on Ouster's commercial trajectory," said Ouster CEO Angus Paca

    4/14/26 8:00:00 AM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer

    Former assistant professor of epidemiology, immunology, and infectious disease at the Harvard T.H. Chan School of Public Health and pathology at Harvard Medical School and Brigham and Women's Hospital, Dr. Mina strengthens Invivyd's medical leadership Dr. Mina's research at Harvard focused on antibodies, vaccines, and infectious diseases with special expertise in COVID-19, measles, and other diseases, and will be a significant asset to Invivyd and the advancement of its pipelineWith more than 100 scientific publications and 10,000 citations, as well as hundreds of popular press interviews and op-eds, Dr. Mina is an expert in conducting research and conveying its meaning and impact to healthc

    3/5/26 7:01:00 AM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    Financials

    Live finance-specific insights

    View All

    Getty Images to Release First Quarter 2026 Financial Results on May 11, 2026

    NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. ("Getty Images") (NYSE:GETY), a preeminent global visual content creator and marketplace, announced today that the Company intends to release its first quarter 2026 results after market close on Monday, May 11, 2026, followed by a conference call at 4:30 p.m. (Eastern Time) that same day to discuss the Company's results. The conference call can be accessed live over the phone by dialing 1-800-245-3047, or for international callers, 1-203-518-9765. The conference ID for the call is GETTYQ1. An audio replay will be available for two weeks following the call and can be accessed by dialing 1-844-512-2921, or for internat

    4/22/26 4:07:00 PM ET
    $GETY
    Real Estate

    Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

    GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti

    4/22/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles

    Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can already provide sufficient statistical power to support the high end of anticipated VYD2311 efficacy Invivyd conducted a pre-specified sample size re-estimation analysis when 1,500 of 1,818 enrolled patients reached Day 45 of 90 total days (April 6th), designed to add robustness given future event rate variability; that upsizing was triggered and increases confidence in overall study statistical powerDECLARATION upsizing provides ~500 additional subjects and will likely shift study result timing modestly, by approximately two months, from original "

    4/9/26 7:01:00 AM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADMA
    $ALLR
    $BAOS
    $BOXD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary